CN Patent

CN105037391A — 一种头孢孟多酯钠化合物及其制剂

Assigned to Shandong Luoxin Pharmaceutical Group Hengxin Pharmacy Co., Ltd. · Expires 2015-11-11 · 11y expired

What this patent protects

本发明涉及医药领域，具体讲，涉及一种头孢孟多酯钠三水合物及其制剂，其结构式如式(I)所示；本发明还涉及该头孢孟多酯钠三水合物的药物组合物，该药物组合物的剂型选自口服制剂或注射制剂。经稳定性试验证实，本发明制备得到的头孢孟多酯钠三水合物的稳定性良好，溶解性好，生物利用度高，适于临床应用。

USPTO Abstract

本发明涉及医药领域，具体讲，涉及一种头孢孟多酯钠三水合物及其制剂，其结构式如式(I)所示；本发明还涉及该头孢孟多酯钠三水合物的药物组合物，该药物组合物的剂型选自口服制剂或注射制剂。经稳定性试验证实，本发明制备得到的头孢孟多酯钠三水合物的稳定性良好，溶解性好，生物利用度高，适于临床应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN105037391A
Jurisdiction
CN
Classification
—
Expires
2015-11-11
Drug substance claim
No
Drug product claim
No
Assignee
Shandong Luoxin Pharmaceutical Group Hengxin Pharmacy Co., Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.